This website uses cookies to enhance the user experience.
E

EURON VENTURE GROUP AS926 330 292

Research
Limited company
Ensjøveien 18 0661 OSLO, Norge

EURON VENTURE GROUP AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
NH
Years since formation
4 years
since Jan 19, 2021
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
133,686
1 share class
Total number of shareholders
10
4 companies, 6 persons
Belongs to group of

Financials

Total operating income 2023
305,931
NOK
Annual total result 2023
-1,580,857
NOK
Total equity 2023
-1,871,187
NOK
Last update: Apr 22, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
NH
Chairman-

Others

NameRoleShares
M
MR ØKONOMI AS
Accountant-
Last update: May 27, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
W
WOM INVEST AS
Ordinary shares
41,385
30.96 %
S
SANDERS HOLDING AS
Ordinary shares
31,500
23.56 %
Ordinary shares
16,500
12.34 %
I
I.A HOLDING AS
Ordinary shares
13,375
10 %
Ordinary shares
10,000
7.48 %
Ordinary shares
5,000
3.74 %
S
SHAH HOLDING AS
Ordinary shares
5,000
3.74 %
Ordinary shares
5,000
3.74 %
Ordinary shares
4,461
3.34 %
Ordinary shares
1,465
1.1 %

Shares owned by the EURON VENTURE GROUP AS

NameShare classTotal number of sharesShare
E
EURON CONNECT AS
Ordinary shares
30,000
100 %
E
EURONLABS AS
Ordinary shares
30,000
100 %
P
PEGAZEUS AS
Ordinary shares
2,790,000
93 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2023: NOK 305,931
    Operating profit 2023: NOK -1,521,404
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
305,931
39,024
0
Annual Total Result
-1,580,857
-383,097
-2,131
Total assets
2,577,786
269,704
97,869
Total liabilities
4,448,973
560,034
5,570
Total equity
-1,871,187
-290,330
92,299

P&L

Year202320222021
Total operating income
305,931
39,024
0
Total operating costs
1,827,335
421,760
2,131
Operating result
-1,521,404
-382,737
-2,131
Financial income/costs
-59,452
108
0
Profit before tax
-1,580,857
-382,629
-2,131
Total tax & extraordinary income/cost
0
468
0
Annual Total Result
-1,580,857
-383,097
-2,131

Balance overview

Year202320222021
Total fixed assets
903,863
21,155
0
Total current assets
1,673,923
248,549
97,869
Total assets
2,577,786
269,704
97,869
Short term debt
2,603,973
182,034
5,570
Long term debt
0
0
0
Total liabilities
4,448,973
560,034
5,570
Contributed capital
100,000
100,000
100,000
Retained earnings
-1,971,187
-390,330
-7,701
Total equity
-1,871,187
-290,330
92,299
Total equity and liabilities
2,577,786
269,704
97,869

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology